Literature DB >> 26223667

[Not Available].

C Lenschow1, K Lindner2, A K Müller2, P Barth3, N Senninger2, M Colombo-Benkmann2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26223667     DOI: 10.1007/s00104-015-0061-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  12 in total

1.  The many appearances of papillary carcinoma of the thyroid.

Authors:  W A Hawk; J B Hazard
Journal:  Cleve Clin Q       Date:  1976 WINTER

2.  Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.

Authors:  Marcia S Brose; Christopher M Nutting; Barbara Jarzab; Rossella Elisei; Salvatore Siena; Lars Bastholt; Christelle de la Fouchardiere; Furio Pacini; Ralf Paschke; Young Kee Shong; Steven I Sherman; Johannes W A Smit; John Chung; Christian Kappeler; Carol Peña; István Molnár; Martin J Schlumberger
Journal:  Lancet       Date:  2014-04-24       Impact factor: 79.321

3.  Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.

Authors:  Shruthi Arora; Paul Christos; Anthony Pham; Prashant Desai; A Gabriella Wernicke; Dattatreyudu Nori; K S C Chao; Bhupesh Parashar
Journal:  J Cancer Res Ther       Date:  2014 Jul-Sep       Impact factor: 1.805

4.  Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Ashok R Shaha; R Michael Tuttle; Andrew G Sikora; Ian Ganly
Journal:  Thyroid       Date:  2010-02       Impact factor: 6.568

Review 5.  Papillary thyroid carcinoma tall cell variant.

Authors:  Ronald Ghossein; Virginia A Livolsi
Journal:  Thyroid       Date:  2008-11       Impact factor: 6.568

6.  Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.

Authors:  Jane Bernstein; Renu K Virk; Pei Hui; Avinash Prasad; William H Westra; Giovanni Tallini; Adebowale J Adeniran; Robert Udelsman; Clarence T Sasaki; Sanziana A Roman; Julie A Sosa; Manju L Prasad
Journal:  Thyroid       Date:  2013-09-03       Impact factor: 6.568

7.  The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.

Authors:  Daniele Barbaro; Roberto Mario Incensati; Gabriele Materazzi; Giuseppe Boni; Mariano Grosso; Erica Panicucci; Paola Lapi; Cristina Pasquini; Paolo Miccoli
Journal:  Endocrine       Date:  2013-08-08       Impact factor: 3.633

8.  Prognostic implications of papillary thyroid carcinoma with tall-cell features.

Authors:  Ian Ganly; Tihana Ibrahimpasic; Michael Rivera; Ian Nixon; Frank Palmer; Snehal G Patel; R Michael Tuttle; Jatin P Shah; Ronald Ghossein
Journal:  Thyroid       Date:  2014-01-22       Impact factor: 6.568

Review 9.  Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.

Authors:  Anna Guerra; Vincenzo Di Crescenzo; Alfredo Garzi; Mariapia Cinelli; Chiara Carlomagno; Massimo Tonacchera; Pio Zeppa; Mario Vitale
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

10.  Anaplastic thyroid cancer: multimodal treatment results.

Authors:  Zaki Antonio Taissoun Aslan; Martín Granados-García; Kuauhyama Luna-Ortiz; Francisco Javier Guerrero-Huerta; Antonio Gómez-Pedraza; Silvio A Namendys-Silva; Abelardo Meneses-García; Juliana María Ordoñez-Mosquera
Journal:  Ecancermedicalscience       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.